Abstract

Adult human multipotent neural cell (ahMNC) is a candidate for regeneration therapy for neurodegenerative diseases. Here, we developed a primary clump culture method for ahMNCs to increase the efficiency of isolation and in vitro expansion. The same amount of human temporal lobe (1 g) was partially digested and then filtered through strainers with various pore sizes, resulting in four types of clumps: Clump I > 100 µm, 70 µm < Clump II < 100 µm, 40 µm < Clump III < 70 µm, and Clump IV < 40 µm. At 3 and 6 days after culture, Clump II showed significantly higher number of colonies than the other Clumps. Moreover, ahMNCs derived from Clump II (ahMNCs-Clump II) showed stable proliferation, and shortened the time to first passage from 19 to 15 days, and the time to 1 × 109 cells from 42 to 34 days compared with the previous single-cell method. ahMNCs-Clump II had neural differentiation and pro-angiogenic potentials, which are the characteristics of ahMNCs. In conclusion, the novel clump culture method for ahMNCs has significantly higher efficiency than previous techniques. Considering the small amount of available human brain tissue, the clump culture method would promote further clinical applications of ahMNCs.

Highlights

  • Neuronal death in human neurodegenerative diseases (NDs) is progressive and irreversible [1,2]

  • neural stem cells (NSCs) have been cultured by neurosphere culture methods [29,31,33,35,36,37,38,39,40,41]

  • We and others have reported that adherent culture methods showed better growth of NSCs compared to neurosphere culture methods, while cultured cells maintained their stemness and normal karyotypes [22,42,43,44]

Read more

Summary

Introduction

Neuronal death in human neurodegenerative diseases (NDs) is progressive and irreversible [1,2]. The lack of spontaneous recovery potential of the human adult brain makes it hard to reverse the disease process of NDs in the clinic [1,2]. Among various types of stem cells, mesenchymal stem cells (MSCs) are the most advanced in clinical trials for NDs [3]. MSCs may have limited regenerative potential for NDs due to their embryologic origin. Neural stem cells (NSCs) have been introduced and focused on to treat NDs because of their superior neural differentiation potential [4,5,6,7]. XEpxepreirmimenentatlalDDeseisgignnaannddMMoorrpphhoollooggiieess ooff CClluummppss HHumumanantetemmppoorraall lloobbee ttiissssuueess((NNSS1188-0-0070T7LTLanadndNSN1S8-1080-80T0L8)TwL)erwe edrieviddievdidinetdo isnmtoallsmpiaecllespi(e1ces (1gg)),,aannddtthheenn ppaarrtitaialllylyddisissosocicaitaetdedinintotoclculummpspsphpyhsyicsaicllayllyanadndeneznyzmyamtiactailclya.llyE.acEhacphropdruocdtuwctaws as filftielrteerdedthtrhoruoguhghthtrhereekeiknidnsdosfocfecllelsltrsatrianienresr(s1(0100,07,07,0a,nadnd4040μmμm) i)nindidffieffreernetnctocmombibniantaiotinosns(F(iFgiugurere1A). Th1eAfi).ltTrhaetiofinltrraetsiounlteredsuinltefoduirntfyopuerstyopfecsluomf cplusm; >p1s0;0>1μ0m0 μ(Cmlu(CmlupmI)p, 7I)0,~7100~100μ0mμm(C(lCulmumppIII)I,)4, 04–0–7700μm (Cμlumm(pClIuImI),paInIId), a

Optimal Clump Size to Isolate and Expand ahMNCs
Discussion
Study Approval
Clump Culture
In Vitro Differentiation
Immunocytochemistry
In Vivo Matrigel Plug Assay
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call